Johns Hopkins Medicine researchers have shown that just two doses of psilocybin given with supportive psychotherapy produced rapid and large reductions in depression symptoms. Such treatments have been proven to last for up to a year. The FDA has given MDMA the designation of "breakthrough therapy" for the treatment of depression.
Multiple studies have found MDMA-assisted psychotherapy was significantly more effective at treating patients with persistent PTSD than unassisted psychotherapy. Ketomine, psilocybin, LSD, mescaline and DMT have also shown to be significantly more effective in the treatment of PTSD than traditional medications and therapy.
Psilocybin has been shown to treat alcoholism and addition in a number of studies. In one study, more than 80% of participants drastically reduced their drinking after just two treatments of psilocybin and half had completely quit drinking altogether.
MindMed, a biotech company, has revealed promising results that LSD is an effective treatment for generalized anxiety disorder. They found that patients experienced meaningful and lasting symptom reduction.
Treatment with psilocybin, when done in an interpersonally supportive setting, has been shown to result in. rapid and significant reductions in overall OCD symptoms.
The landmark studies done by John Hopkins University on psilocybin have proven highly effective in easing the distress that comes with a terminal diagnosis.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.